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Table 3. Age-adjusted stepwise multiple linear regression and Pearson
correlation analysis
Dependent
variables
Independent
variables b  SE p
r
coefﬁcients p
cIMT
Waist
Circumference
0.0040.0001 <0.001 0.728 <0.001
FMD %
Waist
Circumference
0.070.002 <0.001 -0.521 <0.001
The presence
of LBW
-0.0280.01 <0.04 -0. 255 <0.04
cIMT ¼ carotid intima-media thickness, FMD ¼ ﬂow-mediated dilatation, LBW¼ low birth
weight
Table 1. Distribution of eNOS genotypes according to cardiac lesions.
ASD; atrial septal defect, ASVD; Atrioventricular septal defect, PDA; Patent ductus arteriosus,
TOF; Tetralogy of Fallot, VSD; Ventricular septal defect
O
R
A
L
SOP-086
Association between e-NOS gene Polymorphisms and Cardiac Anomaly in
Children with Down Syndrome
Recep Eroz1, Mesut Okur2, Mehmet Selcuk Bektas3, Suleyman Gulsen3,
Anzel Bahadır4, Yasin Türker5, Cemalettin Gunes2
1Department of Medical Genetics, Duzce University, Medical School, Duzce,
2Department of Pediatrics, Duzce University, Medical School, Duzce, 3Women's and
Children's Hospital, Clinic of Pediatrics, Van, 4Department of Biophysics, Duzce
University, Medical School, Duzce, 5Department of Cardiology, Duzce University,
Medical School, Duzce
Background: Down syndrome (DS) is a genetic disorder that results in extra genetic
material from chromosome 21 and seen in patients with congenital heart defects
(CHD). Approximately 40%-50% of patients with Down syndrome have a heart
defect. CHD affects 6–8 babies in every 1000 live births and connect to fetal loss. It
was reported that the frequencies of CHD were ranging from 16-65% in DS.
The gene which encoding the endothelial isoform of nitric oxide synthase (eNOS) is
placed in the long arm of chromosome 7 and includes 26 exons spanning 21 kb of
genomic DNA. Nitric oxide (NO) is synthesized from L-arginine by eNOS. To the
best of our knowledge there is no study to determine the relation between CHD and
eNOS polymorphisms in DS cases. So, we aim to investigate the relationship between
eNOS polymorphisms (exon 894 G/T, promoter -786T/C and intron G10T) and
cardiac lesions to determine whether this polymorphism was associated with CHD in
cases with DS.
Material And Methods: 50DS cases (22 girls and 28 boys)were included in the current
study. The study was conﬁrmed by local ethics committee. In all participants, trans-
thoracic M-mode, two-dimensional, pulsed-wave, continuous-wave and color Doppler
echocardiographic examinations were performed using a General Electric Vingmed
Vivid 7 (GE Vingmed Ultrasound AS, Horten, Norway) using 2.5-3.5MHz transducers.
Blood samples were collected in tubes containing ethylenediamine tetra-aceticacid
(EDTA) and total DNA was isolated via phenol-chloroform extraction methods. The
eNOS single nucleotide polymorphisms (SNPs) were detected by PCR-RFLP methods.
Results: The mean age of cases was 27.78  31.02 month old. The cardiac evaluation
results of cases were: 11 normal, 5 with total atrioventricular septal defect (AVSD), 9
with atrial septal defect (ASD), 9 with ventricular septal defect (VSD), 9 with patent
ductus arteriosus (PDA)+ASD, 2 with PDA + Aortic Regurgitation (AR)+ Mitral
Regurgitation (MR), 2 with tetralogy of Fallot (TOF) and 3 with ASD+VSD. According
to cardiac lesions, the distributions of eNOS genotypes were given in Table 1. The
differences between cases who have not a cardiac lesions (named normal in the text) and
cases with ASD, PDA+ASD and PDA+AR+MR were meaningful for eNOS promoter
(-786T/C) polymorphism (p<0.05) For eNOS exon (894 G/T) polymorphism, the
differences among normal and cases with Total ASVD, ASD, VSD, PDA+ASD,
PDA+AR+MR and ASD+VSD were meaningful (p<0.05). Conversely these two
polymorphisms, there were not a signiﬁcant differences between normal and cases with
at least one cardiac lesion for Intron G10T polymorphism (p>0.05).
Conclusion: It may be said that there is a relation between CHD and both of eNOS
promoter -786T/C and exon 894 G/T polymorphisms in cases with DS. eNOS
polymorphisms may be used as a tool to obtain preliminary knowledge about the risk
of CHDs during prenatal routine screening in DS cases.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAEchocardiography
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Backgrounds: We aimed to measure ﬂow-mediated dilation (FMD), carotid intima-
media thickness (cIMT), and to evaluate the effects of waist circumference (WC), and
body mass index Z (BMI-Z) score on these parameters in obese children.
Methods: This case-control cross-sectional study included 70 obese and 40 non-obese
children aged 7-14 years who presented with various complaints and had no
concomitant diseases. FMD and cIMT were measured in all subjects and correlated
with anthropometric and biochemical factors.
Results: WC, BMI-Z score, systolic and diastolic blood pressure (BP), triglyceride
(TG) and insulin concentrations, and homeostatic model assessment (HOMA) index
were signiﬁcantly higher, whereas high density lipoprotein (HDL) -cholesterol
concentration was signiﬁcantly lower in the obese than in the non-obese group. FMD
values were signiﬁcantly lower, whereas cIMT values were signiﬁcantly higher in
obese than in non-obese subjects. FMD negatively correlated with WC, BMI-Z score,
serum insulin level, HOMA, systolic BP, triglyceride but positively with HDL-
cholesterol. cIMT positively correlated with WC, BMI-Z score, serum insulin level,
HOMA, systolic BP, triglyceride but negatively with HDL-cholesterol.
Conclusions: Increased WC, BMI-Z score, serum insulin level, HOMA, systolic BP,
triglyceride and decreased HDL-cholesterol in obese children contribute to endothelial
dysfunction and early subclinical atherosclerosis compared to their normal weight
peers.LS C39
Table 1. Anthropometric and biochemical characteristics of obese and non-
obese children
Variables
Obese group
(n¼70)
Non- obese
group (n¼40) P Value*
Age (years) 10.6  2.0 11.3  2.2 0.873
Gender, male 40 (57.2) 23 (57.5) 0.871
Weight (kg) 67 (42 – 91) 36 (22 – 47) <0.001
Height, cm 135.5 (110 - 170) 135 (115 - 140) 0.966
BMI (kg/m2) 35 (31 – 38.8) 23 (15 – 24.9) <0.001
BMI - Z score 2.2 ( 1.75 – 2.7) 0.5 (0.4 – 0.7) <0.001
Waist circumference (cm) 85.5 (65 – 99) 64 (51 – 81) <0.001
Systolic BP (mmHg) 120 (90 - 140) 105(90 – 120) <0.001
Diastolic BP (mmHg) 80 (60 – 90) 70 (50 – 85) <0.001
Glucose (mg/dL) 95 (65 – 110) 93 (68 – 96) 0.635
HOMA index 3.3 (0.4 – 8.1) 0.8 (0.2 – 4.5) <0.001
Insulin (mIU/L) 16.5(1.75 – 35) 3.0 (1.9 – 16.7) <0.001
Total cholesterol (mg/dL) 165 (130 – 240) 162 (110 – 214) 0.362
Triglyceride (mg/dL) 95 (75 – 250) 77 (57 – 250) 0.001
LDL-cholesterol (mg/dL) 103(75 – 190) 90 (55 – 153) 0.001
HDL-cholesterol (mg/dL) 43 (35 – 75) 48 (27 – 65) 0.003
CRP 1.5 (0.3 - 6) 1.6 (0.3 - 5.3) 0.735
Data are presented as mean  standard deviation, median (minimum – maximum) or n(%).
Abbreviations: BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-
density lipoprotein; HOMA (Homeostatic model assessment) index ¼ (fasting glucose x fasting
insulin concentration x0.0555)/22.5; IU, international unit; LDL, low-density lipoprotein; * by
independent sample t-test or Mann-Whitney U-test, as appropriate.
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STable 2. Carotid intima-media thickness and ﬂow-mediated dilation of obese
and non-obese children
Variables
Obese group
(n¼70)
Non-obese
group (n¼40) p value*
Flow-mediated
dilatation (%)
5.75 (5.1 – 19.8) 9.7 (7.8 – 26.7) <0.001
Right carotid
intima-media
thickness (mm)
0.59(0.41 – 0.68) 0.45 (0.32 – 0.58) <0.001
Left carotid
intima-media
thickness (mm)
0.59 (0.44 – 0.70) 0.44 (0.32 – 0.60) <0.001
Mean carotid
intima-media
thickness (mm)
0.60 (0.43 – 0.68) 0.43 (0.33 – 0.59) <0.001
Data are presented as mean  standard deviation, median (minimum –maximum) or n (%). *
by Mann-Whitney U test
Table 3. Spearman rank correlation analysis of ﬂow mediated dilation (FMD)
and carotid intima-media thickness (cIMT), with anthropometric and
biochemical variables
FMD CIMT
Variable r p r p
Age - 0.273 0.022 0.340 0.004
Obesity duration - 0.105 0.389 0.076 0.534
Waist circumference - 0.404 0.001 0.343 0.004
BMI Z-score - 0.275 0.021 0.241 0.044
Insulin - 0.400 0.001 0.521 <0.001
HOMA index - 0.403 0.001 0.515 <0.001
Systolic BP - 0.353 0.003 0.309 0.009
Diastolic BP - 0.106 0.420 0.223 0.063
Triglyceride - 0.370 0.002 0.331 0.005
HDL-Cholesterol 0.371 0.002 -0.304 0.011
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Background: High-density lipoprotein cholesterol (HDL-c) levels are inversely
related to risk for developing coronary artery disease (CAD). HDL particles are
heterogeneous in size and composition. They may be differentially associated with
other cardiovascular risk factors. The aim of the present study was to evaluate inde-
pendent relationship in HDL subfraction distribution and HDL-associated enzyme
activities between CAD severity and normal subjects.
Materials-Methods: Total of 101 patients with stable coronary artery disease, and 64
healthy subjects were enrolled in the study. Serum levels of lipoprotein-associated-
phospholipase A2 (Lp-PLA2), Paraoxonase 1 (PON1), HDL subfraction distribution
were measured to compare patient and control subjects.
Results: While marked decrease in plasma levels of HDL-C and SHDL subfraction
was determined in subjects with at least 1 vessel-plugged compared to control
participant (p<0.001) total HDL-C level for more severe type of coronary artery
disease was lower than those of less severe type (p<0.05). Also signiﬁcant increase in
Lp (a) level was observed in patients with 2 and 3 vessel-plugged compared to those
of the other groups (p<0.05) Plasma HDL-Lp PLA2 enzyme level was higher in the
control group compared to each vessel disease category (p<0.001). However, no
statically signiﬁcant change was found in PON1 enzyme activity of patients with CAD
though had the same trend as HDL-Lp PLA2 enzyme level. Also, statically insig-
niﬁcant chances among plasma hs CRP levels of study subgroups were an intriguing
ﬁnding. Signiﬁcant correlations between SHDL fraction and both HDL-associated
enzymes were found only in 3 vessel-plugged patients. Plasma level of SHDL sub-
fraction was negatively correlated with both PON1 activity (r:-0.551, p<0.012) and
HDL-Lp PLA2 enzyme level (r: -0.596, p<0.065) in patients with 3 vessel-plugged.
Plasma SHDL, HDL-Lp PLA2 enzyme and Lp (a), signiﬁcantly differed between
subjects with CAD and control participant.
Conclusion: We reported signiﬁcant correlation total and SHDL subfraction between
patients and control groups. But negative correlation was found between SHDL
subfraction level and PON1 and HDL-Lp PLA2 enzyme level in patients with 3
vessel-plugged.Table 1
Variables
Control
(n: 64)
1 vessel-
plugged
(n: 33)
2 vessel-
plugged
(n: 48)
3 vessel-
plugged
(n: 20)
Age (years), XSD 549* 608 639 597
BMI (kg/m2), XSD 31 (30-33) 29 (28-31) 28 (27-29) 29 (29-21)
Waist Circumference
(cm), XSD
10514 10211 10112 10212
Gender, male, % (n) 41 (26)* 52 (17)* 72 (36) 85 (17)
Hypertension, % (n) 25 (16)z 58 (19) 52 (26) 44 (17)
Dyslipidemia, % (n) 61 (39) 55 (18) 58 (29) 50 (10)
Diabetes, % (n) 18 (12) 16 (5) 26 (13) 35 (7)
Smoking, % (n) 8 (5)z 15 (5) 23 (11) 35 (7)
Distribution of demographic features in the individuals with and without angiographic ﬁndings.
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